Melinda French Gates donates $215 million to women's health, including first-ever menopause funding
By
Laura Trujillo
Summary
Melinda French Gates is donating $215 million to improve women's health, with a historic focus on menopause and midlife women. This marks her first investment in midlife women's health, following over $400 million in women's health funding over the past two years. The article highlights her advocacy for contraceptives, abortion access, and the broader societal pattern where women are expected to step up when men fail to address critical health issues.
Source
bskyMelinda French Gates donates $215 million to women's health, including first-ever menopause fundingbit.lyKey quotes
· 3 pulledI'm both using my voice here and my money to say this is incredibly important.
We ought to be pouring a lot more money into women's health.
When men don't do the right thing, people look to women for answers.
You might also wanna read
Anthropic and Gates Foundation launch $200 million AI partnership for global health and development
Anthropic has formed a $200 million partnership with the Gates Foundation to provide grant funding, Claude AI usage credits, and technical s
anthropic.com·1mo ago
Melinda Gates’ venture firm backs Magnify Ventures’ $46.6M Fund II
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
Experts at HLTH Europe discuss using AI and better data to close the women's health gap
The article reports on discussions at HLTH Europe in Amsterdam about closing the women's health gap through AI and better data. Experts high
mdsc.pe·12d ago
Even as Elon Musk calls philanthropy ‘very hard,’ everyday Americans gave a record $617 billion—despite feeling the squeeze over the cost of living
Juno: AI Health Companion for Chronic Illness Reaches 100K Patients and $75K MRR
Juno is an AI-powered health companion built specifically for people living with chronic illness. Co-founded by Isaac and Marshall—both of w
Product Hunt·26d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.